Radiopharm Theranostics RADX
NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT

Radiopharm Theranostics (RADX) Total Debt (2024 - 2026)

Updated

Radiopharm Theranostics' Total Debt came in at $182,827 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 11.1% from $205,568 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics' Total Debt was $175,045, down 99.5% from FY2025.

  • Going back by fiscal year, Total Debt was $32.1 million in FY2025 and $220,289 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 182,827.16
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 182,827.16
Jun 30, 2025 205,568.32
Dec 31, 2024 29.54 Mn
Jun 30, 2024 220,288.67
API Access

Radiopharm Theranostics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RADX&period=max&api_key=YOUR_API_KEY